A post-hoc PREDMETH analysis presented at ERS 2026 links lower baseline FVC and shorter disease duration with greater FVC gains on first-line therapy.
Vivienne Kahlmann
Advertisement
Vivienne Kahlmann, a PhD candidate at Erasmus MC and a pulmonologist specializing in interstitial lung diseases at Leiden University Medical Center.
Articles by Vivienne Kahlmann
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
RELIEVE-AD-PEDs: Dupilumab Sustains Adolescent Atopic Dermatitis Control at 1 Year
2
Targeting the Disease Mechanism in PFIC, With Hisamitsu Hayashi, PhD
3
10 Nephrology Headlines You Missed in Q3 2026
4
Top Reason for Leaving HAE Attacks Untreated, Survey Finds
5